Introduction
For pharmaceutical, health, and wellness brands, counterfeit listings on Amazon are not just a commercial problem—they are a public‑health risk. Fake supplements, mislabelled health devices, or counterfeit over‑the‑counter (OTC) products can cause serious harm, trigger regulatory scrutiny, and permanently damage trust in your brand. In 2026, as consumers increasingly turn to Amazon for health‑related purchases, the need for a rigorous, safety‑first enforcement strategy has never been greater.
This article outlines a practical framework for pharma, health, and wellness brands to combat counterfeit listings on Amazon in 2026. It focuses on prioritising high‑risk products, building evidence that underscores safety and compliance, and aligning marketplace enforcement with regulatory and customer‑support processes.
Why Health and Pharma Are High‑Risk Categories
Counterfeiters target health and wellness products for several reasons:
- High demand and recurring purchases for supplements, vitamins, and personal care items
- Complex regulatory environments that can confuse consumers about what is legitimate
- Significant price margins on branded health products, making fakes highly profitable
In 2026, common counterfeit or high‑risk items on Amazon include:
- Dietary supplements and vitamins
- Skincare and cosmeceutical products with active ingredients
- OTC medications and first‑aid items (where permitted)
- Health devices such as thermometers, blood‑pressure monitors, and testing kits
These products may look authentic externally but differ in formulation, dosage, sterility, or device accuracy—creating real safety risks.
For a detailed overview of Amazon’s 2026 counterfeit removal mechanics, see: How to Remove Counterfeit Listings from Amazon: The 2026 Process.
Step 1: Prioritise Products with Direct Health Impact
Not all health and wellness SKUs carry the same level of risk. Start by mapping your catalogue into tiers:
- Tier 1 – High risk: Ingestibles (supplements, vitamins), topicals with active ingredients, medical or diagnostic devices.
- Tier 2 – Medium risk: Personal care items, non‑active cosmetics, wellness accessories.
- Tier 3 – Lower risk: General wellness products with minimal safety implications.
Focus your initial enforcement efforts on Tier 1 products, where counterfeits can cause direct harm and regulatory exposure. Create a short “priority list” of 5–10 SKUs to monitor and report on first.
Step 2: Align Amazon Enforcement with Regulatory Compliance
For pharma and health brands, Amazon enforcement should not operate in isolation from regulatory and quality teams. Key alignment points include:
- Label and packaging compliance: Ensure your genuine products meet all local regulatory requirements (ingredient lists, batch numbers, expiry dates, warnings). This makes it easier to spot non‑compliant fakes.
- Adverse event tracking: Log any customer complaints or adverse events that may be linked to suspected counterfeits. These can strengthen enforcement reports and, in serious cases, justify escalation.
- Recall and alert processes: If a counterfeit batch is identified, coordinate with Amazon Brand Registry support and, where appropriate, relevant health authorities to issue targeted warnings or recalls.
This alignment ensures that your Amazon enforcement supports broader safety and compliance obligations.
Step 3: Build Evidence That Highlights Safety and Compliance Gaps
Amazon reviewers respond to clear, specific risks. For health and pharma products, your reports should emphasise:
- Label discrepancies: Missing or incorrect ingredient lists, dosage instructions, batch numbers, or expiry dates.
- Packaging anomalies: Poor print quality, misspellings, missing regulatory symbols, or tampered seals.
- Product differences: Variations in colour, texture, smell, or device performance compared to genuine items.
A strong evidence package might include:
- Time‑stamped screenshots of the infringing listing and seller storefront
- Test buy documentation: photos or video of unboxing, close‑ups of labels, batch codes, and packaging
- Side‑by‑side comparisons of genuine vs. suspect items, highlighting regulatory and visual differences
Where applicable, reference specific regulatory requirements (e.g., mandatory warnings, certification marks) that the counterfeit fails to meet.
Step 4: Use Brand Registry and RAV with Precision
Amazon Brand Registry is essential for health and pharma brands. It enables:
- Access to Report a Violation (RAV) with faster review times than public forms
- Eligibility pathways to Project Zero for instant counterfeit removals
- Enhanced content tools (A+ Content, Brand Stores) to educate customers on authenticity
To protect your RAV acceptance rate:
- File one violation type per report (e.g., trademark counterfeit only).
- Be explicit about what is infringing: logo on product or packaging, trademark in title, copied images, false health claims.
- Avoid reporting unauthorised but genuine sellers as counterfeits; this is a common cause of rejected reports and damaged acceptance rates.
Maintaining a high acceptance rate (ideally 90%+ over six months) can unlock Project Zero, allowing instant removal of clear counterfeit listings—critical for high‑risk health products.
For more on the underlying process, see: How to Remove Counterfeit Listings from Amazon: The 2026 Process.
Step 5: Educate Customers and Reduce Confusion
Counterfeit health products thrive on consumer confusion. Reduce that confusion by:
- Publishing a clear “How to verify authenticity” guide on your website and Amazon Brand Store, with images of genuine packaging, labels, and security features.
- Clearly listing official sales channels and whether Amazon is an authorised retailer for specific products.
- Encouraging customers to report suspicious products via a dedicated email or form, and providing guidance on what information to include (photos, batch numbers, order details).
This not only protects buyers; it also generates additional evidence you can use in RAV filings.
Step 6: Coordinate with Distribution and Retail Partners
Health and pharma brands often sell through multiple channels: Amazon, pharmacies, clinics, and other retailers. To prevent counterfeits from slipping in:
- Share enforcement intelligence (repeat sellers, suspicious SKUs, packaging anomalies) with key distributors and retail partners.
- Ensure packaging and authentication features are consistent across channels so customers and partners can easily spot fakes.
- Align on a unified messaging about official sales channels, warranty or return policies, and how to report suspected counterfeits.
This reduces the risk that counterfeiters exploit gaps between channels to introduce fakes into otherwise trusted supply chains.
A Focused 90‑Day Health & Pharma Enforcement Plan
To make this actionable, consider a 90‑day sprint:
Days 1–30
- Confirm trademark and regulatory compliance in core markets (US, EU, UK, IN, etc.)
- Enrol in Amazon Brand Registry and audit current RAV performance
- Identify 5–10 Tier 1 (high‑risk) SKUs for priority enforcement
Days 31–60
- Implement a weekly scan of priority ASINs for new sellers and suspicious listings
- Build standard evidence templates highlighting regulatory and safety differentiators
- Begin disciplined RAV filing for counterfeit listings on priority SKUs
Days 61–90
- Review RAV outcomes and refine evidence based on acceptance/rejection reasons
- Update website and Amazon content with authenticity guidance and safety information
- Share enforcement insights with regulatory, quality, and distribution teams
By the end of this period, most health and pharma brands will have a tighter, risk‑based enforcement loop that protects both customers and brand integrity.
Final Thought
For pharma, health, and wellness brands in 2026, Amazon counterfeit enforcement is inseparable from patient safety, regulatory compliance, and long‑term trust. By prioritising high‑risk SKUs, building evidence that highlights safety and compliance gaps, and aligning marketplace enforcement with regulatory and distribution processes, brands can reduce the impact of fakes and protect the wellbeing of their customers.
For a detailed view of Amazon’s 2026 counterfeit removal process and how it applies to health and pharma categories, read: How to Remove Counterfeit Listings from Amazon: The 2026 Process.
Views: 3 · 30s+ reads: 0